Usefulness of bone density measurement in fallers.

Archive ouverte

Blain, Hubert | Rolland, Yves | Beauchet, Olivier | Annweiler, Cédric | Benhamou, Claude-Laurent | Benetos, Athanase | Berrut, Gilles | Audran, Maurice | Bendavid, Sauveur | Bousson, Valérie | Briot, Karine | Brazier, Michel | Breuil, Véronique | Chapuis, Laure | Chapurlat, Roland | Cohen-Solal, Martine | Cortet, Bernard | Dargent, Patricia | Fardellone, Patrice | Feron, Jean-Marc | Gauvain, Jean-Bernard | Guggenbuhl, Pascal | Hanon, Olivier | Laroche, Michel | Kolta, Sami | Lespessailles, Eric | Letombe, Brigitte | Mallet, Eric | Marcelli, Christian | Orcel, Philippe | Puisieux, François | Seret, Patrick | Souberbielle, Jean-Claude | Sutter, Bruno | Trémollières, Florence | Weryha, Georges | Roux, Christian | Thomas, Thierry

Edité par CCSD ; Elsevier Masson -

International audience. The objective of this systematic literature review is to discuss the latest French recommendation issued in 2012 that a fall within the past year should lead to bone mineral density (BMD) measurement using dual-energy X-ray absorptiometry (DXA). This recommendation rests on four facts. First, osteoporosis and fall risk are the two leading risk factors for nonvertebral fractures in postmenopausal women. Second, BMD measurement using DXA supplies significant information on the fracture risk independently from the fall risk. Thus, when a fall occurs, the fracture risk increases as BMD decreases. Third, osteoporosis drugs have been proven effective in preventing fractures only in populations with osteoporosis defined based on BMD criteria. Finally, the prevalence of osteoporosis is high in patients who fall and increases in the presence of markers for frailty (e.g., recurrent falls, sarcopenia [low muscle mass and strength], limited mobility, and weight loss), which are risk factors for both osteoporosis and falls. Nevertheless, life expectancy should be taken into account when assessing the appropriateness of DXA in fallers, as osteoporosis treatments require at least 12months to decrease the fracture risk. Another relevant factor is the availability of DXA, which may be limited due to geographic factors, patient dependency, or severe cognitive impairments, for instance. Studies are needed to better determine how the fall risk and frailty should be incorporated into the fracture risk evaluation based on BMD and the FRAX® tool.

Consulter en ligne

Suggestions

Du même auteur

Intérêt de l'ostéodensitométrie chez les sujets chuteurs

Archive ouverte | Blain, Hubert | CCSD

National audience. La présente revue de la littérature a pour objectif d'argumenter les nouvelles recommandations françaises publiées en 2012 retenant le risque de chute, évalué par l'antécédent de chute dans la der...

[Weakening osteopathies, chronic kidney disease, malabsorption, biological anomalies of calium/phosphorus metabolism: appropriate indications for a reasoned reimbursment of serum vitamin D measurement]. Ostéopathies fragilisantes, maladie rénale chronique, malabsorptions, anomalies biologiques du métabolisme phosphocalcique : les bonnes indications pour un remboursement raisonné du dosage de vitamine D

Archive ouverte | Souberbielle, Jean-Claude | CCSD

National audience. No abstract available

Trabecular Bone Score: Where are we now?

Archive ouverte | Bousson, Valérie | CCSD

International audience. The Trabecular Bone Score is a rather new index obtained at the lumbar spine at the same time as a real bone mineral density. It was developed to reflect bone microarchitecture. It was propos...

Chargement des enrichissements...